Aperio Group, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$2,000
-86.7%
994
-91.1%
0.00%
Q3 2017$15,000
-63.4%
11,161
-57.7%
0.00%
Q2 2017$41,000
-51.8%
26,3960.0%0.00%
-100.0%
Q1 2017$85,000
+150.0%
26,396
+5.9%
0.00%
Q4 2016$34,000
+88.9%
24,920
+115.0%
0.00%
Q3 2016$18,000
-69.5%
11,591
+3.5%
0.00%
-100.0%
Q1 2016$59,000
-57.2%
11,194
-11.4%
0.00%0.0%
Q2 2015$138,00012,6350.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders